ABVC BioPharma, Inc. Increase (Decrease) in Prepaid Expenses, Other
ABVC BioPharma, Inc. (ABVC) reported Increase (Decrease) in Prepaid Expenses, Other of -$12.95 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-04-15.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpensesOther · last filed 2025-04-15
- ABVC BioPharma, Inc. increase (decrease) in prepaid expenses, other for the quarter ending 2024-12-31 was $1.23K.
- ABVC BioPharma, Inc. increase (decrease) in prepaid expenses, other for the quarter ending 2023-12-31 was -$74.00K.
- ABVC BioPharma, Inc. increase (decrease) in prepaid expenses, other for the quarter ending 2023-09-30 was -$27.20K.
- ABVC BioPharma, Inc. increase (decrease) in prepaid expenses, other for the quarter ending 2022-09-30 was -$1.03M.
- ABVC BioPharma, Inc. increase (decrease) in prepaid expenses, other for fiscal 2024 was -$12.95K.
- ABVC BioPharma, Inc. increase (decrease) in prepaid expenses, other for fiscal 2023 was -$101.93K.
- ABVC BioPharma, Inc. increase (decrease) in prepaid expenses, other for fiscal 2017 was -$3.81K.
- ABVC BioPharma, Inc. increase (decrease) in prepaid expenses, other for fiscal 2016 was -$3.81K.
| Period end | Increase (Decrease) in Prepaid Expenses, Other 3 month | Increase (Decrease) in Prepaid Expenses, Other 6 month | Increase (Decrease) in Prepaid Expenses, Other 9 month | Increase (Decrease) in Prepaid Expenses, Other 12 month |
|---|---|---|---|---|
| 2024-12-31 | $1.23K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | -$12.95K 10-K · filed 2025-04-15 | ||
| 2024-09-30 | -$14.18K 10-Q · filed 2024-11-14 | |||
| 2023-12-31 | -$74.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | -$101.21K derived: sum of 2 quarters · filed 2025-04-15 | -$101.93K 10-K · filed 2025-04-15 | |
| 2023-09-30 | -$27.20K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$27.92K 10-Q · filed 2024-11-14 | ||
| 2023-06-30 | -$720.00 10-Q · filed 2023-08-14 | |||
| 2022-09-30 | -$1.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-15 | -$243.06K 10-Q · filed 2023-11-15 | ||
| 2022-06-30 | $784.71K 10-Q · filed 2023-08-14 | |||
| 2017-09-30 | -$3.81K 10-KT · filed 2018-04-13 | |||
| 2016-09-30 | -$3.81K 10-KT · filed 2018-04-13 |